2 August 2024
US FDA expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment…
1 August 2024
Caledonia Investments plc Transaction in own shares Caledonia Investments plc (“Caledonia”) announces that on 31 July 2024 it purchased from Winterflood Securities Limited 15,772…
F&C Investment Trust PLC (the ‘Company’ or ‘F&C’) today announces its results for the six months ended 30 June 2024. · The net asset value (‘NAV’) total return…
SHELL PLC2nd QUARTER 2024 AND HALF YEAR UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTS Quarters – $ million Half year Q2 2024 Q1 2024…
Interim results for six months ended 30 June 2024 Delivering on all fronts in H1: consistent growth, improving profitability, strong product pipeline and significant…
31 July 2024
31 July 2024 Consistent, stable financial performance as we ramp up our investments in growth; underlying EBITDA of $12.1 billion and interim ordinary dividend of…
Trading Update James Halstead plc, the commercial flooring manufacturer and international distributor, is providing the following trading update ahead of its results for the…
COLEFAX GROUP PLC (“Colefax” or the “Group”) Preliminary Results for the year ended 30 April 2024 Colefax is an international designer and distributor of…